Lantheus Holdings, Inc. (LNTH) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in United States, listed on NasdaqGM. Market cap 6.54B USD. 52-week range 50.16 to 111.86 USD. Trailing P/E 24.2. Data as of 2026-10-09.
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in diagnosis and treatment of heart, cancer, and other diseases worldwide. The company offers DEFINITY, an injectable ultrasound enhancing agent used in echocardiography exams; TechneLite, a technetium generator for nuclear medicine procedures; Xenon-133, a radiopharmaceutical gas to assess pulmonary function; Neurolite, an injectable imaging agent to identify the area ...